| Presentation | 2016-01-28 [Invited Talk] The key supports for developing new drugs and medical devices in Japan Yutaka Natsumeda, |
|---|---|
| PDF Download Page |  PDF download Page Link |
| Abstract(in Japanese) | (See Japanese page) |
| Abstract(in English) | Although Japan is far behind USA or EU countries in developing new drugs and innovative medical devices, it would not be difficult to catch up and outrun. The key is to find and collaborate with the expert partners in the areas from preclinical studies and clinical trials to its practical use towards the next-generation medical care. In 2015 Dr. Satoshi Omura received Nobel Prize with his discovery of avermectin, anti-parasitic substance. In order to shed on light on the weak points and the necessary key supports in Japan, it would be informative to overview how avermectin was developed, modified to ivermectin and successfully contributed to the progress in medical care. |
| Keyword(in Japanese) | (See Japanese page) |
| Keyword(in English) | Advanced Medical Care / Developed in Japan / Nobel Prize / Ivermectin / Quality of Clinical Trials / Matching / Partnering |
| Paper # | MICT2015-41 |
| Date of Issue | 2016-01-21 (MICT) |
| Conference Information | |
| Committee | MICT / ASN / MoNA |
|---|---|
| Conference Date | 2016/1/28(2days) |
| Place (in Japanese) | (See Japanese page) |
| Place (in English) | Hotel Okada |
| Topics (in Japanese) | (See Japanese page) |
| Topics (in English) | Ambient intelligence, ICT for Medical, Healthcare and Sports, etc |
| Chair | Ryuji Kohno(Yokohama National Univ.) / Hiroshi Tohjo(NTT) / Hiroaki Morino(Shibaura Inst. of Tech.) |
| Vice Chair | Masaru Sugimachi(National Cerebral and Cardiovascular Center) / Takahiro Aoyagi(Tokyo Inst. of Tech.) / Hiroo Sekiya(Chiba Univ.) / Hiraku Okada(Nagoya Univ.) / Kiyohito Yoshihara(KDDI R&D Labs.) / Ryoichi Shinkuma(Kyoto Univ.) |
| Secretary | Masaru Sugimachi(NICT) / Takahiro Aoyagi(Nagoya Inst. of Tech.) / Hiroo Sekiya(Kanagawa Inst. of Tech.) / Hiraku Okada(NTT) / Kiyohito Yoshihara(KDDI R&D Labs.) / Ryoichi Shinkuma(Kumamoto Univ.) |
| Assistant | Kohei Ohno(Meiji Univ.) / Keisuke Shima(Yokohama National Univ.) / Tomoko Tateyama(Ritsumeikan Univ.) / Yuichi Igarashi(Hitachi) / Katsuhiro Naito(Aichi Inst. of Tech.) / Kiyohiko Hattori(NICT) / Hiroshi Fujita(Fujitsu Labs.) / Takuro Yonezawa(Keio Univ.) / Yoshifumi Morihiro(NTT DoCoMo) / Hisashi Kurasawa(NTT) / Makoto Suzuki(Univ. of Tokyo) |
| Paper Information | |
| Registration To | Technical Committee on Healthcare and Medical Information Communication Technology / Technical Committee on Ambient intelligence and Sensor Networks / Technical Committee on Mobile Network and Applications |
|---|---|
| Language | JPN |
| Title (in Japanese) | (See Japanese page) |
| Sub Title (in Japanese) | (See Japanese page) |
| Title (in English) | [Invited Talk] The key supports for developing new drugs and medical devices in Japan |
| Sub Title (in English) | |
| Keyword(1) | Advanced Medical Care |
| Keyword(2) | Developed in Japan |
| Keyword(3) | Nobel Prize |
| Keyword(4) | Ivermectin |
| Keyword(5) | Quality of Clinical Trials |
| Keyword(6) | Matching |
| Keyword(7) | Partnering |
| 1st Author's Name | Yutaka Natsumeda |
| 1st Author's Affiliation | Key Support for Life Innovation(KSLION) |
| Date | 2016-01-28 |
| Paper # | MICT2015-41 |
| Volume (vol) | vol.115 |
| Number (no) | MICT-438 |
| Page | pp.pp.13-16(MICT), |
| #Pages | 4 |
| Date of Issue | 2016-01-21 (MICT) |